NMC
AVTX icon

NEA Management Company’s Avalo Therapeutics AVTX Stock Holding History

NEA Management Company’s Portfolio AVTX Stock Details AVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-207
Closed -$506K – 44
2017
Q3 		$506K Hold
207
– – 0.02% 43
2017
Q2 		$341K Hold
207
– – 0.01% 43
2017
Q1 		$402K Hold
207
– – 0.01% 38
2016
Q4 		$524K Hold
207
– – 0.02% 38
2016
Q3 		$2.52M Hold
207
– – 0.11% 32
2016
Q2 		$1.31M Hold
207
– – 0.07% 36
2016
Q1 		$2.22M Hold
207
– – 0.15% 33
2015
Q4 		$1.2M Buy
+207
New +$2.27M 0.08% 34

Other funds holding AVTX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return